Advanced Orthopedics New England — Bloomfield, Connecticut

Advanced Orthopedics New England is a clinical research site located in Bloomfield, Connecticut, United States 06002.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Advanced Orthopedics New England has participated in 1 clinical trials.

Therapeutic areas: Degenerative and Traumatic Pathology of the Knee, Degenerative and Traumatic Pathology of the Shoulder and Elbow, Degenerative and Traumatic Pathology of the Foot and Ankle.

Sponsors: Arthrex, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bloomfield

Browse all research sites in Connecticut · View every site in Bloomfield

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Advanced Orthopedics New England?

Advanced Orthopedics New England has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Advanced Orthopedics New England conducted?

Advanced Orthopedics New England has 1 clinical trials on record. Their work covers Degenerative and Traumatic Pathology of the Knee, Degenerative and Traumatic Pathology of the Shoulder and Elbow, Degenerative and Traumatic Pathology of the Foot and Ankle.

Is Advanced Orthopedics New England accredited by Crixeo Clinical Trials?

Advanced Orthopedics New England has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Advanced Orthopedics New England?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.